Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gonadal Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01832415
What this trial is testing

First Line Ovarian Cancer Treatment - Cohort Study

Who this might be right for
Epithelial Ovarian Cancer
ARCAGY/ GINECO GROUP 500
Large-scale testing (Phase 3)Study completedNCT00002568
What this trial is testing

Combination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial Cancer

Who this might be right for
Ovarian Cancer
Gynecologic Oncology Group 470
Early research (Phase 1)UnknownNCT02457650
What this trial is testing

T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies

Who this might be right for
Bladder CarcinomaBreast CancerEsophagus Carcinoma+7 more
Shenzhen Second People's Hospital 36
Testing effectiveness (Phase 2)Looking for participantsNCT04585750
What this trial is testing

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Who this might be right for
Advanced Solid TumorAdvanced Malignant NeoplasmMetastatic Cancer+27 more
PMV Pharmaceuticals, Inc 300
Early research (Phase 1)Active Not RecruitingNCT06421935
What this trial is testing

M9466 Alone or in Combination in Advanced Solid Tumors (DDriver 501)

Who this might be right for
Advanced Solid Tumor
EMD Serono Research & Development Institute, Inc. 60
Not applicableUnknownNCT04528940
What this trial is testing

Tumor Grade Determines PD-1/PDL-1 Expression

Who this might be right for
Endometrial CancerOvarian Cancer
RWJ Barnabas Health at Jersey City Medical Center 100
Not applicableStudy completedNCT01966991
What this trial is testing

Prenatal Screening for Down Syndrome With DNAFirst

Who this might be right for
Trisomy 21Trisomy 18Trisomy 13+1 more
Women and Infants Hospital of Rhode Island 100
Not applicableLooking for participantsNCT07463508
What this trial is testing

Evaluation of Bile Acid Concentrations and Their Signaling as Markers of Testicular Tumorigenesis and Germ Cell Tumor Chemosensitivity

Who this might be right for
Testicular Germ Cell Cancer
University Hospital, Clermont-Ferrand 20
Post-approval studies (Phase 4)Study completedNCT00795808
What this trial is testing

PCOSMIC Trial - PolyCystic Ovary Syndrome, Metformin for Infertility With Clomiphene

Who this might be right for
Polycystic Ovary Syndrome
University of Auckland, New Zealand 171
Not applicableEnded earlyNCT01077440
What this trial is testing

Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant

Who this might be right for
Cancer SurvivorChronic Myeloproliferative DisordersLeukemia+6 more
Vanderbilt University 24
Testing effectiveness (Phase 2)Study completedNCT06087289
What this trial is testing

Evaluate the Safety of KAND567, in Combination With Carboplatin Therapy, in Women With Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Epithelial Ovarian CancerFallopian Tube CancerPeritoneal Cancer
Novakand Pharma AB 18
Early research (Phase 1)Looking for participantsNCT06885697
What this trial is testing

Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma

Who this might be right for
MesotheliomaNeoplasmsStomach Neoplasms+5 more
National Cancer Institute (NCI) 100
Testing effectiveness (Phase 2)Ended earlyNCT03933813
What this trial is testing

Evaluation and Treatment of Iron Deficiency in Ovarian Cancer Patients

Who this might be right for
Epithelial Ovarian CancerAnemiaIron Deficiency Anemia
University of Wisconsin, Madison 9
Early research (Phase 1)Study completedNCT02146313
What this trial is testing

A Study Evaluating the Safety and Pharmacokinetics of DMUC4064A in Participants With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic NeoplasmsOvarian Neoplasms
Genentech, Inc. 35
Early research (Phase 1)Ended earlyNCT00637390
What this trial is testing

A Phase I Study of Alemtuzumab in Patients With Relapsed Ovarian/Primary Peritoneal Cancer.

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Cancer
University of Michigan Rogel Cancer Center 3
Not applicableStudy completedNCT00340210
What this trial is testing

Extended Follow-up of Columbia, MO Serum Bank Participants

Who this might be right for
Breast CancerEndometrial CancerOvarian Cancer
National Cancer Institute (NCI) 6,720
Not applicableLooking for participantsNCT06392997
What this trial is testing

Evaluation of Salivary RNA in Subjects Scheduled for Surgery for a Gynecologic Pathology

Who this might be right for
Gynecologic DiseaseGynecologic CancerEndometriosis+5 more
ZIWIG 2,500
Testing effectiveness (Phase 2)Study completedNCT01001910
What this trial is testing

Pemetrexed and Carboplatin in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Recurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma
Albert Einstein College of Medicine 22
Large-scale testing (Phase 3)Study completedNCT00262990
What this trial is testing

Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Neoplasms
Novartis Pharmaceuticals 829
Large-scale testing (Phase 3)Not Yet RecruitingNCT07550205
What this trial is testing

Tiaoshen Anti-cancer Protocol and CBT for Insomnia and Survival in Ovarian Cancer

Who this might be right for
Ovarian Neoplasms MalignantSleep Initiation and Maintenance DisordersMedicine, Chinese Traditional+2 more
Shanghai Municipal Hospital of Traditional Chinese Medicine 360
Next Page